Future Oncology · 2018 · 23 citations · 17 references
MedicineGeneticsOncologyCancer GeneticsMolecular OncologyOncogenesCancer TranscriptomicsHepatic PathologyHepatobiliary CancerHepatocellular CarcinomaLiver CancerLiver DiseasePrognostic BiomarkersRecurrence-free SurvivalTp53 Mutations
AIM: To assess the prognostic value of RAMP3 expression in terms of overall survival (OS) and recurrence-free survival (RFS) in hepatocellular carcinoma (HCC) patients. MATERIALS & METHODS: Immunochemistry staining was performed to detect RAMP3 expression. Data in the Cancer Genome Atlas-Liver Hepatocellular Cancer were used for secondary analysis. RESULTS: RAMP3 expression was significantly downregulated in HCC tissues than in normal liver tissues. Increased RAMP3 expression was an independent prognostic factor of favorable OS (hazard ratio [HR]: 0.772, 95% CI: 0.689-0.864; p < 0.001) and RFS (HR = 0.719, 95% CI: 0.633-0.817; p < 0.001). High RAMP3 expression was associated with significantly better RFS in both TP53 mutant and wildtype groups. CONCLUSION: High RAMP3 RNA expression is an independent prognostic factor of favorable OS and RFS in patients with HCC.
17
Jaesook Roh, Chia Lin Chang, Alka Bhalla et al. · Journal of Biological Chemistry · 2004 · 442 citations · Full text
IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo
Avinashnarayan Venkatanarayan, Payal Raulji, William Norton et al. · Nature · 2014 · 131 citations
Medicine, Cancer Biology, Oncology +13
Itidal Kaafarani, Samantha Fernandez-Sauze, Caroline Bérenguer et al. · The FASEB Journal · 2009 · 72 citations
Medicine, Oncology, Pharmacology +16